Device type · PTI
Non-Coring (Huber) Needle
Last checked: Nov 19, 2026Source: openFDAMethods & limitations
Product code
PTI
General Hospital
Device class
Class II
FDA decisions since 2015
14
510(k), De Novo and PMA
Adverse event reports
33
Received Nov 1, 2025 to Nov 19, 2026
How FDA classifies it
- Device type
- Non-Coring (Huber) Needle
- Product code
- PTI
- Device class
- Class II
- Review panel
- General Hospital
- Regulation
- 21 CFR 880.5570
- Specialty
- Hospital Medicine & Nursing
- FDA record
- Classification database entry for PTI
Latest FDA decisions
The 8 newest of 14 since 2015.
- 25G Huber Needle510(k)
K254095 · Decided Sep 18, 2026 · 273 days after receipt
Device type: Non-Coring (Huber) Needle (PTI) · Hospital Medicine & Nursing
Sb-Kawasumi Laboratories, Inc.
K252355 · Decided Nov 26, 2025 · 120 days after receipt
Device type: Non-Coring (Huber) Needle (PTI) · Hospital Medicine & Nursing
Promisemed Hangzhou Meditech Co., Ltd.
K251138 · Decided May 13, 2025 · 29 days after receipt
Device type: Non-Coring (Huber) Needle (PTI) · Hospital Medicine & Nursing
11 more FDA decisions with a free account
Reports received
33
Received Nov 1, 2025 to Nov 19, 2026
Malfunction reports
22
67% of reports
Injury reports
11
33% of reports
Death reports
0
0.0% of reports
Adverse event reports received per month
By the date FDA received each report, stacked by event type. The newest month is incomplete.
- Malfunction
- Injury
- Death
- Other
View as table
| Month | Malfunction | Injury | Death | Other |
|---|---|---|---|---|
| Dec 23 | 1 | 0 | 0 | 0 |
| Jan 24 | 2 | 1 | 0 | 0 |
| Feb 24 | 2 | 1 | 0 | 0 |
| Mar 24 | 8 | 1 | 0 | 0 |
| Apr 24 | 6 | 1 | 0 | 0 |
| May 24 | 1 | 0 | 0 | 0 |
| Jun 24 | 1 | 0 | 0 | 0 |
| Jul 24 | 5 | 0 | 0 | 0 |
| Aug 24 | 2 | 0 | 0 | 0 |
| Sep 24 | 1 | 0 | 0 | 0 |
| Oct 24 | 1 | 0 | 0 | 0 |
| Nov 24 | 3 | 0 | 0 | 0 |
| Dec 24 | 0 | 0 | 0 | 0 |
| Jan 25 | 1 | 0 | 0 | 0 |
| Feb 25 | 1 | 0 | 0 | 0 |
| Mar 25 | 6 | 0 | 0 | 0 |
| Apr 25 | 2 | 1 | 0 | 0 |
| May 25 | 1 | 0 | 0 | 0 |
| Jun 25 | 2 | 0 | 0 | 0 |
| Jul 25 | 1 | 1 | 0 | 0 |
| Aug 25 | 2 | 1 | 0 | 0 |
| Sep 25 | 6 | 0 | 0 | 0 |
| Oct 25 | 1 | 2 | 0 | 0 |
| Nov 25 | 3 | 0 | 0 | 0 |
| Dec 25 | 2 | 0 | 0 | 0 |
| Jan 26 | 2 | 0 | 0 | 0 |
| Feb 26 | 1 | 1 | 0 | 0 |
| Mar 26 | 2 | 0 | 0 | 0 |
| Apr 26 | 2 | 0 | 0 | 0 |
| May 26 | 4 | 0 | 0 | 0 |
| Jun 26 | 1 | 1 | 0 | 0 |
| Jul 26 | 0 | 2 | 0 | 0 |
| Aug 26 | 0 | 3 | 0 | 0 |
| Sep 26 | 4 | 1 | 0 | 0 |
| Oct 26 | 1 | 3 | 0 | 0 |
| Nov 26 | 0 | 0 | 0 | 0 |
Manufacturers named most often
Last 12 months. Bigger sellers get more reports. This is not a ranking of safety.
1 more in this ranking with a free account
Device problems as coded
Last 12 months. FDA's terms. A report can carry several.
- Fluid/Blood Leak11
- Break7
- Adverse Event Without Identified Device or Use Problem3
7 more in this ranking with a free account
Patient problems as coded
Last 12 months. FDA's terms. A report can carry several.
- No Clinical Signs, Symptoms or Conditions22
- Fall4
- Cognitive Changes3
7 more in this ranking with a free account
Recent recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Z-2660-2020 · Started Jun 19, 2020 · Posted by FDA Jul 20, 2020
Reason given: Potential development of cracks or breaks in the tubing near the Luer or Y site of the device. Devices that have developed breaks or cracks can cause leakage resulting in exposure to chemicals such a chemotherapeutics or biohazard material (e.g., blood). A crack or break could result in potential blood loss, catheter...
Cause as FDA categorized it: Process control
Z-2661-2020 · Started Jun 19, 2020 · Posted by FDA Jul 20, 2020
Reason given: Potential development of cracks or breaks in the tubing near the Luer or Y site of the device. Devices that have developed breaks or cracks can cause leakage resulting in exposure to chemicals such a chemotherapeutics or biohazard material (e.g., blood). A crack or break could result in potential blood loss, catheter...
Cause as FDA categorized it: Process control
Z-2662-2020 · Started Jun 19, 2020 · Posted by FDA Jul 20, 2020
Reason given: Potential development of cracks or breaks in the tubing near the Luer or Y site of the device. Devices that have developed breaks or cracks can cause leakage resulting in exposure to chemicals such a chemotherapeutics or biohazard material (e.g., blood). A crack or break could result in potential blood loss, catheter...
Cause as FDA categorized it: Process control
9 more recall records with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.